Total Funding
26
56
Total FundingDebt Financing raised
Growth Score
-2 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
58098
Thylacine Bio engages in developing a peptide platform for pandemic preparedness.
- Anne Moscona: Founding Scientist & Inventor
- Matteo Porotto: Founding Scientist & Inventor
About the Company
Thylacine Bio engages in developing a peptide platform for pandemic preparedness. The platform can be rapidly tuned and applied to new and existing pathogens. It targets conserved regions less susceptible to mutation, unlocking efficacy across variants. The resulting antivirals are potent, self-administered, and easily distributed.
Women Founded
